Golenser J, Tsafack A, Amichai Y, Libman J, Shanzer A, Cabantchik Z I
Department of Parasitology, Kuvin Center for Infectious and Tropical Diseases, Hadassah Medical School, Israel.
Antimicrob Agents Chemother. 1995 Jan;39(1):61-5. doi: 10.1128/AAC.39.1.61.
Hydroxamate-based chelators of iron are potent inhibitors of in vitro growth of Plasmodium falciparum. Two types of such chelators, the natural desferrioxamine and the synthetic reversed siderophore RSFileum2, are prototypes of antimalarial agents whose action spectra differ in the speed of action, stage dependence, and degree of reversibility of effects. This work explores the possibility of improving the antimalarial efficacy of these agents by using them in various combinations on in vitro cultures of P. falciparum. Growth assessment was based both on total nucleic acid synthesis and on parasitemia. The results indicate that the synthetic reversed siderophore more than complements the antimalarial action of desferrioxamine when applied during either ring, trophozoite, or mixed stages. The combined drug effects were significantly higher than the additive effect of the individual drugs. Qualitatively similar results were obtained for both reversible effects and irreversible (i.e., sustained) effects. Following an 8-h window of exposure the combined drug treatment caused parasite growth arrest and prevented its recovery, even 3 days after the treatment. The fact that such a combination of iron chelators displays a wider action spectrum than either drug alone has implications for the design of chemotherapy regimens.
基于异羟肟酸的铁螯合剂是恶性疟原虫体外生长的有效抑制剂。两种此类螯合剂,天然的去铁胺和合成的反向铁载体RSFileum2,是抗疟药物的原型,其作用谱在作用速度、阶段依赖性和效应可逆程度方面存在差异。这项工作探讨了通过将这些药物以各种组合用于恶性疟原虫的体外培养来提高其抗疟疗效的可能性。生长评估基于总核酸合成和疟原虫血症。结果表明,当在环状体、滋养体或混合阶段应用时,合成的反向铁载体比去铁胺的抗疟作用更具互补性。联合药物效应显著高于各药物的相加效应。对于可逆效应和不可逆(即持续)效应,都获得了定性相似的结果。在8小时的暴露窗口后,联合药物治疗导致寄生虫生长停滞并阻止其恢复,甚至在治疗后3天也是如此。这种铁螯合剂组合显示出比单独任何一种药物更广泛的作用谱这一事实,对化疗方案的设计具有启示意义。